KRAS and neoplasm: Acetylation of RAS at lysine 104 interferes with guanine nucleotide exchange factor‐induced nucleotide exchange, inhibiting the transforming activity of KRAS and thereby reducing cell proliferation, colony formation and tumour burden in mice.80